tirzepatide ban update 🚨There's been a lot of confusion lately, so let's clear this up… Compounded GLP-1 medications (like semaglutide and tirzepatide) are not banned entirely — but access is changing. The FDA has ended Semaglutide Compound Ban: FDA Ends

Persistent and severe asthma has a prevalence of 510% among patients with asthma, with these patients using a disproportionally large amount of all asthma resources [4]

Amycretin (also known as zenagamtide, development code NN9487) is a novel, first-in-class, unimolecular dual agonist that simultaneously activates two receptor systems: GLP-1 receptors and amylin receptors

Gore, M

Expected weight loss outcomes : While many patients experience significant reductions, the percentage of weight loss can vary widely

Instead of relying only on food tracking or motivation alone, this program combines medical treatment with behavior change in a way that feels practical, human, and doable